Delivery Order SPE2DB24D2205-SPE2DB25FEBHC

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $4,017.09 firm fixed-price delivery order is for the supply of 4,567,944 vials of the vaccine PRIORIX. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.42, is for the delivery of PRIORIX vials, a vaccine product. It is a firm fixed-price delivery order contract type, with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,913.60 firm fixed-price delivery order is for the PRIORIX vaccine product. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,039.90 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,455.54, is for the delivery of PRIORIX VIALS, a vaccine product. It is a firm fixed-price delivery order contract with a period of performance ending on March 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $38,534.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 19, 2024 with an ultimate completion date of April 22, 2024. The contract has no set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.24 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of March 28, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,392.56 Firm Fixed Price contract is a Delivery Order under the DLA's $999,999,999 Indefinite Delivery Contract (IDC) with Amerisourcebergen, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order is for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,675.77 firm fixed-price delivery order is for PRIORIX VIALS, a vaccine product. The award has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,879.00, is a firm fixed-price delivery order for PRIORIX VIALS. The award has an ultimate completion date of November 6, 2024 and was issued on November 5, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBHC
    Delivery Order

This federal contract award, valued at $5,047.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for 4,567,996,497 units of the vaccine PRIORIX VIALS, with a completion date of April 23, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/22/25, 9:44 AM